161 related articles for article (PubMed ID: 38360812)
1. Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/STAT3 signaling via transactivation of IL-6ST and IL-6 genes.
Jin X; Shang B; Wang J; Sun J; Li J; Liang B; Wang X; Su L; You W; Jiang S
Cell Death Dis; 2024 Feb; 15(2):148. PubMed ID: 38360812
[TBL] [Abstract][Full Text] [Related]
2. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
[TBL] [Abstract][Full Text] [Related]
3. The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway.
Attia YM; Tawfiq RA; Ali AA; Elmazar MM
Sci Rep; 2017 Oct; 7(1):12502. PubMed ID: 28970500
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
5. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
You W; Chen B; Liu X; Xue S; Qin H; Jiang H
Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
[TBL] [Abstract][Full Text] [Related]
7. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
[TBL] [Abstract][Full Text] [Related]
8. The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
Liu X; Chen B; You W; Xue S; Qin H; Jiang H
Cancer Lett; 2018 Jan; 412():194-207. PubMed ID: 29074425
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway.
Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S
J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642
[TBL] [Abstract][Full Text] [Related]
11. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways.
Bi Y; Cao J; Jin S; Lv L; Qi L; Liu F; Geng J; Yu Y
Mol Cell Biochem; 2016 Apr; 415(1-2):1-11. PubMed ID: 26983629
[TBL] [Abstract][Full Text] [Related]
13. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells.
Li J; Lan T; Zhang C; Zeng C; Hou J; Yang Z; Zhang M; Liu J; Liu B
Oncotarget; 2015 Jan; 6(2):1031-48. PubMed ID: 25504436
[TBL] [Abstract][Full Text] [Related]
15. IL-17 promoted metastasis of non-small-cell lung cancer cells.
Li Q; Han Y; Fei G; Guo Z; Ren T; Liu Z
Immunol Lett; 2012 Dec; 148(2):144-50. PubMed ID: 23089548
[TBL] [Abstract][Full Text] [Related]
16. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
[TBL] [Abstract][Full Text] [Related]
17. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
[TBL] [Abstract][Full Text] [Related]
18. APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling.
Tang CH; Qin L; Gao YC; Chen TY; Xu K; Liu T; Ren T
Clin Transl Med; 2022 May; 12(5):e876. PubMed ID: 35605028
[TBL] [Abstract][Full Text] [Related]
19. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
[TBL] [Abstract][Full Text] [Related]
20. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
